
eBook - ePub
Textbook of Interventional Cardiovascular Pharmacology
- 704 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
Textbook of Interventional Cardiovascular Pharmacology
About this book
While all interventional cardiologists have access to pharmacopeial texts and databases and are aware of the growing number of pharmacological agents in the armamentarium, questions arise as to the ideal agent or combination of agents in differing patient situations.
This superb text offers the reader coverage of all the major pharmacological t
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, weāve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere ā even offline. Perfect for commutes or when youāre on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Textbook of Interventional Cardiovascular Pharmacology by Nicolas Kipshidze,Jawad Fareed,Patrick W. Serruys,Jeff Moses in PDF and/or ePUB format, as well as other popular books in Medicine & Cardiology. We have over one million books available in our catalogue for you to explore.
Information
Topic
MedicineSubtopic
CardiologyTable of contents
- Cover
- Half Title
- Title Page
- Copyright Page
- Table of Contents
- Contributors
- Foreword
- Foreword
- Preface
- Acknowledgments
- Frontmatter
- 1 An overview of hemostasis and thrombosis
- 2 Principles of antiplatelet therapy
- 3 Glycoprotein llb/Illa inhibitors
- 4 Adenosine diphosphate receptor inhibitors
- 5 Phosphodiesterase inhibitors: dipyridamole and cilostazol
- 6 Heparin, low molecular weight heparin
- 7 Direct thrombin inhibition in percutaneous coronary intervention
- 8 Clinical application of direct antithrombin inhibitors in acute coronary syndrome
- 9 Oral antithrombin drugs
- 10 Rationale for direct factor Xa inhibitors in acute coronary syndromes
- 11 Combined anticoagulant and antiplatelet therapy
- 12 Fibrinolytic therapy
- 13 Resistance to antiplatelet drugs
- 14 Lipid-lowering agents
- 15 Improving the diagnosis and management of high blood pressure in the cardiac patient
- 16 Homocysteine regulators
- 17 Role of systemic antirestenotic drugs and results of current clinical trials
- 18 Role of systemic antineoplasic drugs in the treatment of restenosis after percutaneousĀ stent implantation
- 19 Antioxidants
- 20 Iron chelation: deferoxamine and beyond
- 21 Stent-mediated local drug delivery
- 22 The application of controlled drug delivery principles to the developmentĀ of drug-eluting stents
- 23 Brachytherapy
- 24 Polymers and drug-eluting stents
- 25 Utilization of antiproliferative and antimigratory compounds for the preventionĀ of restenosis
- 26 Anti-inflammatory drugs, sirolimus, and inhibition of target of rapamycin and itsĀ effect on vascular diseases
- 27 Anti-migratory drugs and mechanisms of action
- 28 Antioangiogenetic drugsāmechanisms of action
- 29 Vasculoprotective approach for restenosis
- 30 Vascular endothelial growth factor
- 31 Gene therapy: role in myocardial protection
- 32 Antisense approach
- 33 Principles of photodynamic treatment
- 34 Angiogenesis and myogenesis
- 35 Growth factor therapy
- 36 Cell transplantation for cardiovascular repair
- 37 Clinical trials in cellular therapy
- 38 The heart failure patient
- 39 The acute coronary syndrome patient
- 40 Cardiovascular interventional pharmacology in the diabetic patient
- 41 Atrial fibrillation during catheterization
- 42 Contrast-induced nephropathy after percutaneous coronary interventions
- 43 Erectile dysfunction
- 44 Peripheral arterial disease
- 45 Pharmacotherapy peri-percutaneous coronary intervention
- 46 Pharmacologic management of patients with CTO interventions
- 47 Newer pharmacologic approaches targeting receptors and genes
- 48 Carotid artery stenting
- 49 Anticoagulants in peripheral vascular interventions
- 50 Repair of AAAs
- 51 Interventions for structural heart disease
- 52 Pharmacologic use of ethanol for myocardial septal ablation
- Epilogue: Anticoagulant management of patients undergoing interventionalĀ procedures
- Appendix A
- Appendix B
- Index